NF-Kappa B Activity as a Predictor and Diagnostic for the Two Sub-Groups of Diffuse Large B Cell Lymphoma
Application
Diagnostic assay that classifies non-Hodgkin's lymphoma specifically diffuse large B cell lymphoma (DLBCL) into two groups, which respond differently to chemotherapy.
Key Benefits
Uses gene expression profiling for classification.
Provides classification of sub-group for a better selection of more specific and effective treatments.
Market...
Published: 7/28/2023
Contributor(s): Leon Bernal-Mizrachi
|